Co-Diagnostics, Inc.
CODX
$0.40
-$0.06-12.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 162.90K | 50.30K | 149.30K | 206.90K | 161.10K |
| Total Other Revenue | -- | -- | 0.00 | 434.30K | 2.50M |
| Total Revenue | 162.90K | 50.30K | 149.30K | 641.10K | 2.66M |
| Cost of Revenue | 32.10K | 21.60K | 255.10K | 297.40K | 212.10K |
| Gross Profit | 130.80K | 28.70K | -105.70K | 343.70K | 2.44M |
| SG&A Expenses | 3.21M | 3.43M | 6.64M | 5.35M | 4.17M |
| Depreciation & Amortization | 291.40K | 280.40K | 357.10K | 351.20K | 338.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.22M | 8.60M | 12.06M | 10.88M | 10.34M |
| Operating Income | -8.06M | -8.55M | -11.91M | -10.23M | -7.68M |
| Income Before Tax | -7.72M | -7.52M | -11.04M | -9.67M | -7.58M |
| Income Tax Expenses | 12.30K | 12.00K | -8.20K | 22.20K | 20.60K |
| Earnings from Continuing Operations | -7.73M | -7.53M | -11.03M | -9.70M | -7.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.73M | -7.53M | -11.03M | -9.70M | -7.60M |
| EBIT | -8.06M | -8.55M | -11.91M | -10.23M | -7.68M |
| EBITDA | -7.77M | -8.27M | -11.55M | -9.88M | -7.34M |
| EPS Basic | -0.23 | -0.24 | -0.36 | -0.32 | -0.25 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.24 | -0.20 | -0.15 |
| EPS Diluted | -0.23 | -0.24 | -0.36 | -0.32 | -0.25 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.24 | -0.20 | -0.15 |
| Average Basic Shares Outstanding | 33.11M | 32.05M | 30.88M | 30.49M | 30.12M |
| Average Diluted Shares Outstanding | 33.11M | 32.05M | 30.88M | 30.49M | 30.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |